[Submucous mucous membrane support in intrinsic sphincter insufficiency. A therapeutic approach in female stress incontinence].
Urethral bulking agents are an attractive alternative for treating patients with intrinsic sphincter deficiency (ISD), i.e., type III urinary stress incontinence. These endoscopic techniques are minimally invasive and can be used in high-risk patients. As bulking agents, Teflon, autologous fat, collagen, silicone particles, and detachable microballoons have been the object of considerable clinical research. Teflon forms granulomas in the surrounding tissue and tends to migrate and is now considered obsolete. More recently, human collagen, autologous cartilage, Bioglass, and hyaluronic acid with dextranomer and polycarbon particles have come under clinical investigation, but long-term results are still lacking. The optimal bulking agent should be nondegradable and biologically inert and should not migrate or change its bulking capability. To date, there is no consensus on the best agent fulfilling these requirements, but encapsulated substances appear most promising.